Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using Internet-based nursing for patients with hip fractures

Official title: Application and Effect Evaluation of "Internet + Nursing" Scheme Based on Fracture Liaison Service Model in Patients With Hip Fragility Fracture

Run by The Fourth Affiliated Hospital of Zhejiang University School of Medicine · NCT06975254 · Data updated 2026-11-12

This study is testing whether an online nursing program can help older patients with hip fractures recover better by providing them with ongoing support and education after surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment94 (estimated)
SponsorThe Fourth Affiliated Hospital of Zhejiang University School of Medicine
Academic / other
Locations1 site (Yiwu, Zhejiang)
StatusRecruiting
StartedApril 1, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2027
Registry record updatedMay 16, 2025
Trial IDNCT06975254 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who have been diagnosed with a closed hip fragility fracture and are scheduled for surgical intervention.

Probably not a fit

Patients with psychiatric or neurological disorders, multiple fractures, or terminal illnesses are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the application of an 'Internet + nursing' program tailored for patients suffering from hip fragility fractures, which are common in the elderly due to osteoporosis. The intervention aims to enhance postoperative care through continuous nursing support and education, addressing gaps in rehabilitation guidance and self-care capabilities. Patients will receive routine nursing care supplemented by digital resources to improve their recovery outcomes. The study emphasizes the importance of standardized management for hip fractures to reduce complications and improve quality of life.

Why it matters

Potential benefit: If successful, this approach could significantly improve recovery rates and quality of life for patients with hip fragility fractures.

How similar studies have gone: Other studies have shown promise in using digital health interventions for improving patient outcomes, suggesting that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria Age ≥ 18 years

Voluntarily signed informed consent

Diagnosis of hip fragility fracture (closed type)

Scheduled for surgical intervention

Adequate communication and comprehension abilities

Ability of patient or caregiver to operate smart electronic devices

Exclusion Criteria History of psychiatric or neurological disorders (e.g., dementia, schizophrenia)

Polytrauma (multiple fractures or major concomitant injuries)

Metastatic cancer, metabolic bone disease, or terminal illness

Insulin-dependent diabetes mellitus

Thyroid disease

Inability to participate due to other medical or social factors

Where it's running

  • The Fourth Affiliated Hospital of Zhejiang University School of Medicine
    Yiwu, Zhejiang, China
    Recruiting

Study contacts

  • Principal investigator: Cheng li Yan, Bachelor — The Fourth Affiliated Hospital of Zhejiang UniversitySchool of Medicine
  • Study coordinator: Cheng li Yan, Bachelor
  • Email: yanchengli1208@zju.edu.cn
  • Phone: 86+13757179391

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.